
Tatva Chintan Pharma Chem Ltd is Rated Hold
2026-05-12 10:11:08Tatva Chintan Pharma Chem Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read MoreWhen is the next results date for Tatva Chintan Pharma Chem Ltd?
2026-05-07 23:17:14The next results date for Tatva Chintan Pharma Chem Ltd is scheduled for 16 May 2026....
Read More
Tatva Chintan Pharma Chem Ltd: Technical Momentum Shifts Amid Mixed Market Signals
2026-04-30 08:03:28Tatva Chintan Pharma Chem Ltd, a small-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock’s mixed technical indicators suggest a nuanced outlook for investors navigating the current market environment.
Read More
Tatva Chintan Pharma Chem Ltd is Rated Hold
2026-04-20 10:10:03Tatva Chintan Pharma Chem Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read More
Tatva Chintan Pharma Chem Ltd is Rated Hold by MarketsMOJO
2026-04-09 10:10:03Tatva Chintan Pharma Chem Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read More
Tatva Chintan Pharma Chem Ltd Forms Death Cross, Signalling Bearish Trend Ahead
2026-04-01 18:00:16Tatva Chintan Pharma Chem Ltd, a small-cap player in the Specialty Chemicals sector, has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting a deterioration in the stock’s medium to long-term momentum and raising concerns about sustained weakness ahead.
Read More
Tatva Chintan Pharma Chem Ltd is Rated Hold
2026-03-29 10:10:37Tatva Chintan Pharma Chem Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Dec 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 March 2026, providing investors with the latest insights into its performance and outlook.
Read MoreAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
12-Jun-2026 | Source : BSEIntimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
19-May-2026 | Source : BSETranscript of the earnings call held on 16 May 2026 post announcement of the financial results of the Company for the quarter and financial year ended 31 March 2026.
Compliances-Reg.24(A)-Annual Secretarial Compliance
18-May-2026 | Source : BSESubmission of Annual Secretarial Compliance Report for the financial year ended 31 March 2026 (2025-2026).
Corporate Actions
No Upcoming Board Meetings
Tatva Chintan Pharma Chem Ltd has declared 10% dividend, ex-date: 12 Sep 25
No Splits history available
No Bonus history available
No Rights history available
